Navigation Links
Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.

SAN FRANCISCO, Nov. 4 /PRNewswire-FirstCall/ Medizone International, Inc. (Pink Sheets: MZEI) announces the establishment of a strategic consulting relationship with TDV Global, Inc. ( TDV Global is a highly professional and experienced strategic management consulting firm. Approximately 70% of their business involves consulting for government agencies and projects, the remainder for private enterprise, mostly in the Health and Security Medical fields. TDV Global has assisted Medizone with the founding of its recently established non-profit affiliate, The Canadian Foundation for Global Health (CFGH). Mr. Brad Goble, the President of TDV Global, has been appointed an officer and member of the Board of Directors of the Canadian Foundation for Global Health. Additionally, the offices for the CFGH are being located at TDV Global in Ottawa. Working with Dr. Michael E. Shannon of Medizone International, TDV Global has also played a key role in producing the product development plan for Medizone's Hospital Sterilization Initiative.

Edwin Marshall, Chairman of the Board and CEO of Medizone commented, "Over the past ten years, Dr. Shannon has successfully worked on many different projects with Mr. Goble and his firm. Between the Hospital Sterilization Initiative and founding the CFGH, Medizone has been working with TDV Global since mid-September. I could not be more pleased with the results so far. Given their many current health related activities involving G-8 countries, TDV will assist Medizone in strategically aligning us with government and institutional interests in Canada, the US and Europe. We welcome TDV Global as a vital and strategic partner."

Medizone International, Inc., is a research and development stage company engaged in the development of patented and unpatented technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pathogenic conditions. It is currently developing technology to decontaminate and sterilize hospital surgical suites, emergency rooms and intensive care units.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Web site:

Investor Relations 800-953-3350

SOURCE Medizone International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
2. Chindex International, Inc. Announces Appearances at Additional November Conferences
3. PharmaSmart International, Inc. Redefines Blood Pressure Management through Technology and Pharmacy Focused Patient Services
4. Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2009 Earnings Release Date and Conference Call Information
5. China Yingxia International, Inc. to Promote Benefits of Its Soy Milk Products Over Scandal-Stricken Cows Milk in China
6. Block Imaging International, Inc. Partners with Dicom Solutions, Inc. to Offer New Products
7. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
8. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
9. WaterPure International, Inc. and Everest Water Ltd. Revise Payment Terms of Patent License to Produce Water From Air
10. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
11. Chindex International, Inc. Announces CDC Contract Signing
Post Your Comments:
(Date:11/24/2015)... FL (PRWEB) , ... November 24, 2015 , ... In ... a growing epidemic as deaths from prescription opioids in the United States grew 400 ... cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal drug ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic student Katie Benson received ... in Overland Park, Kansas. Benson, a fifth-trimester student in the university’s College of ... on October 16. , “Katie is very excited and greatly appreciative to receive ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading autism science ... social media and the generosity of people around the world. On December 1, supporters ... to give – and share the personal stories behind those gifts. , Just ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... and engineer of patented products, announces Fragrance by Marcelle, a cosmetic invention which ... The Perfume & Fragrance Manufacturing Market in the US is worth $3 billion ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... st  Scientific Assembly and Annual Meeting of the Radiological ... in Chicago on Nov-29 th through ... st  Scientific Assembly and Annual Meeting of the Radiological Society of ... Chicago on Nov-29 th through Dec-4 th ... will present its revolutionary whole body CZT digital SPECT/CT solution at ...
(Date:11/24/2015)... , Nov. 24, 2015  Family Rentals, ... recently announced the launch of their newly designed, ... --> --> ... --> --> Now, renting ... travel and vacation, just got a whole lot ...
(Date:11/24/2015)... LONDON , November 24, 2015 ... PCSK9 Inhibitors, CETP Inhibitors, MTTP Inhibitors, ApoB Inhibitors and ... areas are going to grow at the fastest rates? ... to 2025, assessing data, trends, opportunities and prospects there. ... graphs. Discover the most lucrative areas in the industry ...
Breaking Medicine Technology: